{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:26:34Z","timestamp":1783632394628,"version":"3.55.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>NASH-associated liver cancer (NALC) is a significant contributor to global cancer mortality, closely linked to the increasing prevalence of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). This study comprehensively examines the global burden of NALC from 1990 to 2021.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study used data from the Global Burden of Disease (GBD) 2021 database to analyze NALC death and age-standardized death rates (ASDR) globally and regionally from 1990 to 2021. We applied Joinpoint regression analysis to assess temporal trends, calculating the annual percent change (APC) and average annual percent change (AAPC). Decomposition analysis was performed to break down mortality changes into contributions from population aging, growth, and epidemiological changes. A frontier analysis was used to evaluate the relationship between NALC burden and sociodemographic development using the Socio-Demographic Index (SDI). Prediction analysis of NALC deaths and ASDR from 2021 to 2045 were estimated using the Nordpred model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>From 1990 to 2021, the global burden of NALC deaths increased significantly, with the ASDR rising from 0.38 per 100,000 in 1990 to 0.48 per 100,000 in 2021. Age-specific data in 2021 revealed that NALC deaths peaked in the 65\u201369 age group for men and 70\u201374 age group for women. Decomposition analysis indicated that population growth was the most significant contributor to the global NALC death toll, followed by population aging and epidemiological changes. Frontier analysis showed that countries like Mongolia and Gambia were farthest from the disease burden frontier, while Morocco and Ukraine were closest. Prediction analysis suggest a significant increase in NALC deaths by 2045 compared to 2021, with a larger rise in deaths among women.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Through this study, a data-driven approach is provided to reduce the global disease burden of NALC. Essential data support for public health prevention strategies is offered, helping guide the development of targeted government interventions. Trends across global regions, countries, age groups, and genders have been analyzed, providing valuable insights for the formulation of evidence-based policies aimed at mitigating the impact of NALC worldwide.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2025.1527328","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T06:58:00Z","timestamp":1739516280000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Global burden and international disparities in NASH-associated liver Cancer: mortality trends (1990\u20132021) and future projections to 2045"],"prefix":"10.3389","volume":"13","author":[{"given":"Qilong","family":"Nie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongwen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoai","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengyu","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunfang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaizhou","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youqing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/apt.15464","article-title":"Characteristics, aetiologies and trends of hepatocellular carcinoma in patients without cirrhosis: a United States multicentre study","volume":"50","author":"Gawrieh","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jhep.2013.08.011","article-title":"Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team","volume":"60","author":"Dyson","year":"2014","journal-title":"J Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.cgh.2015.07.019","article-title":"Hepatocellular carcinoma in the absence of cirrhosis in United States veterans is associated with nonalcoholic fatty liver disease","volume":"14","author":"Mittal","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1053\/j.gastro.2018.08.024","article-title":"Risk of hepatocellular Cancer in patients with non-alcoholic fatty liver disease","volume":"155","author":"Kanwal","year":"2018","journal-title":"Gastroenterology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/hep.22734","article-title":"Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis","volume":"49","author":"Paradis","year":"2009","journal-title":"Hepatology"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/hep.28368","article-title":"Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: a multicenter prospective study","volume":"63","author":"Piscaglia","year":"2016","journal-title":"Hepatology"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ejca.2022.06.051","article-title":"Hepatocellular and extrahepatic cancers in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"173","author":"Thomas","year":"2022","journal-title":"Eur J Cancer"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"100809","DOI":"10.1016\/j.neo.2022.100809","article-title":"Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis: HCC and steatosis or Steatohepatitis","volume":"30","author":"Petrelli","year":"2022","journal-title":"Neoplasia"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13098-022-00976-w","article-title":"Estimates and trends of the global burden of NASH-related liver cancer attributable to high fasting plasma glucose in 1990-2019: analysis of data from the 2019 global burden of disease study","volume":"15","author":"Li","year":"2023","journal-title":"Diabetol Metab Syndr"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13098-022-00885-y","article-title":"Global burden of nonalcoholic steatohepatitis-related liver cancer, 1990-2019: a systematic analysis for the GBD 2019","volume":"14","author":"Pang","year":"2022","journal-title":"Diabetol Metab Syndr"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","article-title":"Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of disease study 2021","volume":"403","author":"Collaborators","year":"2024","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1016\/S0140-6736(24)00769-4","article-title":"Findings from the global burden of disease study 2021","volume":"403","author":"Murray","year":"2024","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of disease study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of disease study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for join point regression with applications to cancer rates","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"key":"ref20","first-page":"171","article-title":"Standardization and decomposition of rates from cross-classified data","volume":"50","author":"Das Gupta","year":"1994","journal-title":"Genus"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e1003138","DOI":"10.1371\/journal.pmed.1003138","article-title":"Population ageing and mortality during 1990-2017: a global decomposition analysis","volume":"17","author":"Cheng","year":"2020","journal-title":"PLoS Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1002\/sim.1481","article-title":"Prediction of cancer incidence in the Nordic countries: empirical comparison of different approaches","volume":"22","author":"M\u00f8ller","year":"2003","journal-title":"Stat Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"103407","DOI":"10.1016\/j.autrev.2023.103407","article-title":"A global assessment of incidence trends of autoimmune diseases from 1990 to 2019 and predicted changes to 2040","volume":"22","author":"Li","year":"2023","journal-title":"Autoimmun Rev"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.kint.2018.04.011","article-title":"Analysis of the global burden of disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016","volume":"94","author":"Xie","year":"2018","journal-title":"Kidney Int"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ejim.2024.04.013","article-title":"Metabolic dysfunction-associated steatotic liver disease: evolution of the final terminology","volume":"124","author":"Portincasa","year":"2024","journal-title":"Eur J Intern Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1007\/s12072-024-10731-0","article-title":"Metabolic (dysfunction)-associated fatty liver disease metrics and contributions to liver research","volume":"18","author":"Suoh","year":"2024","journal-title":"Hepatol Int"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/liv.15139","article-title":"Systematically comparing epidemiological and clinical features of MAFLD and NAFLD by meta-analysis: focusing on the non-overlap groups","volume":"42","author":"Ayada","year":"2022","journal-title":"Liver Int"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"102420","DOI":"10.1016\/j.jceh.2024.102420","article-title":"Comparison of NAFLD, MAFLD, and MASLD prevalence and clinical characteristics in Asia adults","volume":"15","author":"Huang","year":"2025","journal-title":"J Clin Exp Hepatol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"102406","DOI":"10.1016\/j.jceh.2024.102406","article-title":"Evolving global etiology of hepatocellular carcinoma (HCC): insights and trends for 2024","volume":"15","author":"Koshy","year":"2025","journal-title":"J Clin Exp Hepatol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3350\/cmh.2024.0109","article-title":"Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis","volume":"30","author":"Crane","year":"2024","journal-title":"Clin Mol Hepatol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1499013","DOI":"10.3389\/fmed.2024.1499013","article-title":"Non-invasive testing in metabolic dysfunction-associated steatotic liver disease","volume":"11","author":"Dawod","year":"2024","journal-title":"Front. Med."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3390\/ijms222111629","article-title":"Pathophysiological molecular mechanisms of obesity: a link between MAFLD and NASH with cardiovascular diseases","volume":"22","author":"Guti\u00e9rrez-Cuevas","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"6234","DOI":"10.3390\/cancers14246234","article-title":"Metabolic risk factors for hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: a prospective study","volume":"14","author":"Antwi","year":"2022","journal-title":"Cancers (Basel)"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"e209","DOI":"10.1017\/S1368980024001927","article-title":"Identification of Chinese dietary patterns and their relationships with health outcomes: a systematic review and meta-analysis","volume":"27","author":"Hu","year":"2024","journal-title":"Public Health Nutr"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3390\/ijerph17155294","article-title":"Are the Chinese moving toward a healthy diet? Evidence from macro data from 1961 to 2017","volume":"17","author":"Han","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/S2213-8587(21)00118-2","article-title":"Health policy and public health implications of obesity in China","volume":"9","author":"Wang","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1002\/oby.24134","article-title":"One hundred-year secular trends of overweight and obesity in China: effects of age, period, and cohort","volume":"32","author":"Xie","year":"2024","journal-title":"Obesity (Silver Spring)"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1111\/jgh.16501","article-title":"Metabolic-associated fatty liver disease and hepatocellular carcinoma: a prospective study of characteristics and response to therapy","volume":"39","author":"Batt","year":"2024","journal-title":"J Gastroenterol Hepatol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.2147\/JHC.S420603","article-title":"Updates in characteristics and survival rates of hepatocellular carcinoma in a Nationwide cohort of real-world US patients, 2003-2021","volume":"10","author":"Tran","year":"2023","journal-title":"J Hepatocell Carcinoma"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1527328\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T06:58:03Z","timestamp":1739516283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1527328\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":41,"alternative-id":["10.3389\/fpubh.2025.1527328"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2025.1527328","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]},"article-number":"1527328"}}